Related Experiment Video
Updated: Aug 6, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
[Screening for prostate cancer: arguments "in favour"]
H Echo1, S Dominique, V Ravery
1Hôpital Bichat, 46, rue Henri-Huchard, 75877 Paris, France.
Annales D'Urologie
|July 28, 2006
Summary
Prostate cancer screening shows promising early results, with some studies suggesting reduced mortality. French authorities currently recommend individual screening based on available evidence.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Context:
- Prostate cancer represents a significant public health concern.
- The efficacy of mass prostate cancer screening is under ongoing investigation through randomized prospective studies.
- Preliminary findings from these studies are encouraging.
Purpose:
- To evaluate the public health impact and mortality benefits of prostate cancer screening.
- To inform current screening recommendations for prostate cancer.
Summary:
- While definitive evidence from ongoing randomized trials is pending, non-randomized and retrospective studies indicate a potential benefit of screening in reducing prostate cancer mortality.
- Current French scientific authorities recommend individual prostate cancer screening.
Impact:
- The findings contribute to the ongoing debate on the optimal strategy for prostate cancer screening.
- Informs public health policy and clinical practice regarding prostate cancer detection.
